Study on the Pharmacokinetics and Bioequivalence of Erythromycin Ethylsuccinate in Chinese Healthy Volunteers

姜敏,陈岩冰,张红,付军,熊玉卿

DOI: https://doi.org/10.3969/j.issn.1000-2294.2004.01.005

2004-01-01

Abstract:Objective A microbiological assay method was developed and validated to determine erythromycin in human plasma and study the pharmacokinetics profiles and bioequivalence of erythromycin ethylsuccinate tablets(calculated on erythromycin) in healthy volunteers.Mehtods In a randomized two period crossover study,20 healthy male volunteers received single 500 mg dose of erythromycin ethylsuccinate tested tablets and erythromycin reference ethylsuccinate tablets.The plasma concentrations of erythromycin ethylsuccinate were determined by microbiological assay method. The pharmacokinetic parameters of the two preparations and the relative bioavailability of tested tablets after oral administration were calculated with stastic analysis.Results The concentration-time curves of two preparations were fitted to a one-compartment open model with first-order absorption.The main pharmacokinetic parameters of the two domestic preparations were as follows: AUC 0-12(4.62±0.91)and(4.55±0.63)mg/h·L -1,AUC 0-∞(4.83± 0.93)and(4.76± 0.63)mg/h·L -1,c max(1.078±0.357)and(1.061±0.298)mg/L -1,t max( 0.80±0.24)and(0.78±0.18)h,t 1/2ke(2.31±0.25)and(2.33±0.28)h respectively.There were no significant difference between the two preparations.The relative bioavailability of tested tablet was (101.5±11.9)%.ConclusionThe results of statistical analysis showed that the two preparations were bioequivalent.